Home/Filings/4/0000950170-25-073521
4//SEC Filing

Chen Shu-Chih 4

Accession 0000950170-25-073521

CIK 0001488039other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 4:05 PM ET

Size

5.4 KB

Accession

0000950170-25-073521

Insider Transaction Report

Form 4
Period: 2025-05-15
Chen Shu-Chih
DirectorChief Scientific Officer10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2025-05-15+125,000125,000 total
    Exercise: $0.99Exp: 2035-05-15Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]The options shall vest on a quarterly basis over 12 months following May 15, 2025, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued on May 15, 2025 with an exercise price of $0.99, representing the closing stock price on May 15, 2025.

Documents

1 file

Issuer

ATOSSA THERAPEUTICS, INC.

CIK 0001488039

Entity typeother

Related Parties

1
  • filerCIK 0001552127

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:05 PM ET
Size
5.4 KB